KCTD14 Antibody (H-8): sc-393917
- KCTD14 Antibody (H-8) is a mouse monoclonal IgG3 κ provided at 200 µg/ml
- specific for an epitope mapping between amino acids 118-145 within an internal region of KCTD14 of human origin
- recommended for detection of KCTD14 of mouse, rat and human origin by WB, IP, IF and ELISA
- m-IgG3 BP-HRP is the preferred secondary detection reagent for KCTD14 Antibody (H-8) for WB applications. This reagent is now offered in a bundle with KCTD14 Antibody (H-8) (see ordering information below).
KCTD14 Antibody (H-8) is a mouse monoclonal IgG3 antibody that detects KCTD14 in mouse, rat, and human samples through applications such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA). KCTD14, or potassium channel tetramerisation domain containing 14, is a 255 amino acid protein characterized by the presence of a BTB (Broad-Complex, Tramtrack and Bric a brac) domain, which plays a crucial role in the regulation of transcription by influencing chromatin structure and function. KCTD14 is encoded by a gene located on human chromosome 11, a region associated with various genetic disorders, including Jervell and Lange-Nielsen syndrome and Jacobsen syndrome, highlighting KCTD14′s importance in maintaining cellular homeostasis and potential implications in disease. KCTD14′s ability to interact with other proteins involved in potassium channel regulation further underscores anti-KCTD14 antibody (H-8)′s value as an essential tool for researchers studying these complex mechanisms.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
KCTD14 Antibody (H-8) References:
- KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders. | Teng, X., et al. 2019. CNS Neurosci Ther. 25: 887-902. PMID: 31197948
- The emerging role of the KCTD proteins in cancer. | Angrisani, A., et al. 2021. Cell Commun Signal. 19: 56. PMID: 34001146
- Members of the KCTD family are major regulators of cAMP signaling. | Muntean, BS., et al. 2022. Proc Natl Acad Sci U S A. 119: PMID: 34934014
- Network meta-analysis of transcriptome expression changes in different manifestations of dengue virus infection. | Winter, C., et al. 2022. BMC Genomics. 23: 165. PMID: 35220956
- Cancer-associated fibroblast-derived gene signatures predict radiotherapeutic survival in prostate cancer patients. | Zhang, R. and Liu, F. 2022. J Transl Med. 20: 453. PMID: 36195908
- Alphafold Predictions Provide Insights into the Structural Features of the Functional Oligomers of All Members of the KCTD Family. | Esposito, L., et al. 2022. Int J Mol Sci. 23: PMID: 36362127
- A novel DNA methylation-related gene signature for the prediction of overall survival and immune characteristics of ovarian cancer patients. | Wang, S., et al. 2023. J Ovarian Res. 16: 62. PMID: 36978087
- KCTD Proteins Have Redundant Functions in Controlling Cellular Growth. | Rizk, R., et al. 2024. Int J Mol Sci. 25: PMID: 38732215
- Unraveling potential gene biomarkers for dengue infection through RNA sequencing. | Suppiah, J., et al. 2025. Virus Genes. 61: 26-37. PMID: 39397194
- Hormonally-regulated KCTD14 Expression Is Higher in Oocytes from Antral Follicles Compared to Those from Preantral Follicles in Mice, with Implications in Fertility. | Berkel, C. 2025. Reprod Sci.. PMID: 40044995
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
KCTD14 Antibody (H-8) | sc-393917 | 200 µg/ml | $316.00 | |||
KCTD14 Antibody (H-8): m-IgG3 BP-HRP Bundle | sc-550498 | 200 µg Ab; 40 µg BP | $354.00 | |||
KCTD14 (H-8) Neutralizing Peptide | sc-393917 P | 100 µg/0.5 ml | $68.00 |